Oupeptide
Finnrick has tested 165 samples from Oupeptide across 8 products.
Finnrick Vendor Profile
to
Oupeptide
Tracking 8 products
165 total samples tested
Last test 30 Apr 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Ipamorelin | 7 | 21 Aug 2025 | 26 Jan 2026 | |||||
| GHK-Cu | 10 | 14 Aug 2025 | 28 Apr 2026 | |||||
| BPC-157 | 8 | 15 Aug 2025 | 9 Feb 2026 | |||||
| Retatrutide | 58 | 9 Jun 2025 | 30 Apr 2026 | |||||
| Tesamorelin | 14 | 10 Aug 2025 | 28 Apr 2026 | |||||
| Semaglutide | 6 | 5 Aug 2025 | 29 Jan 2026 | |||||
| Tirzepatide | 61 | 3 Jun 2025 | 28 Apr 2026 | |||||
| PT-141 | 1 | 24 Jul 2025 | 24 Jul 2025 | |||||
The Oupeptide samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
4.7
Based on 21 overall satisfaction reports
Ease of Purchase4.6(21)
Payment Methods4.5(21)
Delivery Speed4.4(21)
Packaging Quality4.7(21)
Customer Service4.7(19)
People who submitted test requests to Finnrick gave Oupeptide an average satisfaction rating of 4.7 out of 5 across 21 reports associated with samples received and tested by Finnrick.
Most recent Oupeptide tests
Samples are tested in commercial labs
165
tests
8
products
Scores
AVGMINMAX
First
3 Jun 2025
Last
30 Apr 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 30 Apr 2026 | Retatrutide | View | 10mg | 9.6mg | -4.0% | 99.40% | 0U950 | Silver Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |
| 28 Apr 2026 | Tirzepatide | View | 60mg | 54.9mg | -8.5% | 99.90% | 3/2/2026 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 28 Apr 2026 | Tirzepatide | View | 60mg | 55.7mg | -7.2% | 99.90% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 20mg | 21.1mg | +5.5% | 99.90% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 28 Apr 2026 | Retatrutide | View | 10mg | 9.84mg | -1.6% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 28 Apr 2026 | GHK-Cu | View | 100mg | 81mg | -19.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 28 Apr 2026 | Tesamorelin | View | 10mg | 10.6mg | +6.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
Corrections
- 6 May 2026: Retatrutide
- Data for sample 4z9e34c and 86nyk43 were swapped following a clerical error by Finnrick. On 6 May, the error was corrected.
- 6 May 2026: Tesamorelin
- Data for sample hv46bd2 and f7qjrbk were swapped following a clerical error by Finnrick. On 6 May, the error was corrected.